27
Participants
Start Date
November 7, 2019
Primary Completion Date
March 4, 2021
Study Completion Date
June 14, 2021
zilucoplan
Daily subcutaneous (SC) inection
Placebo
Daily subcutaneous (SC) inection
Northwell Health Neuroscience Institute, Great Neck
University of Pennsylvania, Philadelphia
National Institute of Health, Bethesda
University of Florida Health Jacksonville, Jacksonville
University of South Florida, Tampa
Wesley Neurology Clinic, Memphis
The Ohio State University, Columbus
Washington University School of Medicine in Saint Louis, St Louis
University of Kansas Medical Center, Kansas City
Hôpital Universitaire Pitié Salpêtrière, Paris
The University of Texas Health Science Center at Houston, Houston
Austin Neuromuscular Center, Austin
University of California Los Angeles, Los Angeles
University of California Irvine, Orange
Brigham and Women's Hospital, Boston
Amsterdam UMC, Amsterdam
University College London Hospitals NHS Foundation Trust, London
Salford Royal NHS Barnes Clinical Research Facility, Manchester
Lead Sponsor
Ra Pharmaceuticals
INDUSTRY